At baseline, 95% of patients were treated with an ACE inhibitor or ARB, 16% were on SGLT-2is, 76% were on a statin, and 50% were on an antiplatelet agent
Do not use Wegovy Pills if: You or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) You have had a serious allergic reaction to semaglutide or any of the ingredients in WEGOVY INJECTION or Wegovy Pills Tell your healthcare provider if you: Have or have had problems with your pancreas or kidneys Have type 2 diabetes and a history of diabetic retinopathy Have or have had depression, suicidal thoughts, or mental health issues Are scheduled to have surgery or other procedures that use anesthesia or deep sleepiness (deep sedation) Wegovy Pills contain semaglutide and should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicines
Rigorous monitoring of metabolic, hepatic, and endocrine parameters will be essential in future trials to ensure safety alongside efficacy
l-Carnitine, a nutrient found primarily in red meat, was recently reported to be metabolized by gut microbiota to form TMA via the 2-component Rieske-type l-carnitine oxygenase CntA/B (25, 26), which requires molecular oxygen for activity
